Terms: = Ovarian cancer AND BTG1, P62324, 694, ENSG00000133639 AND Treatment
9 results:
1. Prevalence and predictors for fertility-related distress among 1010 young adults 1.5 years following cancer diagnosis - results from the population-based Fex-Can Cohort study.
Rodriguez-Wallberg KA; Ahlgren J; Smedby KE; Gorman JR; Hellman K; Henriksson R; Ståhl O; Wettergren L; Lampic C
Acta Oncol; 2023 Dec; 62(12):1599-1606. PubMed ID: 37909865
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of hyperthermic intraperitoneal chemotherapy plus cytoreductive surgery for advanced or recurrent ovarian cancer: a systematic evaluation and meta-analysis.
Li H; Liao LJ
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):8135-8143. PubMed ID: 37750641
[TBL] [Abstract] [Full Text] [Related]
3. A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data.
Zhang Q; Ding Y; Shu Y; Chen J
BMC Cancer; 2023 Aug; 23(1):745. PubMed ID: 37568126
[TBL] [Abstract] [Full Text] [Related]
4. Indications for cryopreservation and autotransplantation of ovarian tissue.
Gjeterud J; Kristensen SG; Fedder J
Tidsskr Nor Laegeforen; 2021 Oct; 141(2021-15):. PubMed ID: 34726041
[TBL] [Abstract] [Full Text] [Related]
5. Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients.
Fekete JT; Ősz Á; Pete I; Nagy GR; Vereczkey I; Győrffy B
Gynecol Oncol; 2020 Mar; 156(3):654-661. PubMed ID: 31973910
[TBL] [Abstract] [Full Text] [Related]
6. Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers.
Bai Y; Qiao L; Xie N; Shi Y; Liu N; Wang J
PLoS One; 2017; 12(9):e0184902. PubMed ID: 28922388
[TBL] [Abstract] [Full Text] [Related]
7. Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States.
Melamed A; Hinchcliff EM; Clemmer JT; Bregar AJ; Uppal S; Bostock I; Schorge JO; Del Carmen MG; Rauh-Hain JA
Gynecol Oncol; 2016 Nov; 143(2):236-240. PubMed ID: 27612977
[TBL] [Abstract] [Full Text] [Related]
8. [Expression of serum human epididymis protein 4 in epithelial ovarian cancer and its correlation with prognosis].
Zheng H; Gao YN; Gao WJ; Gao M; Yan X
Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):445-9. PubMed ID: 24119905
[TBL] [Abstract] [Full Text] [Related]
9. Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma.
Tada H; Teramukai S; Fukushima M; Sasaki H
BMC Cancer; 2009 Feb; 9():47. PubMed ID: 19193243
[TBL] [Abstract] [Full Text] [Related]
